Fowler to co-lead antibacterial resistance network
The National Institutes of Health announced today that it has awarded a new six-year, $62 million federal grant to Vance Fowler, MD, MHS , and a group of researchers at Duke and across the country that will allow them to form a national leadership group focused on antibacterial resistance.
Antibacterial resistance has been identified as one of the leading threats to human health worldwide because there is a dwindling pipeline of new antibiotics and, at the same time, bacterial resistance to drugs is growing, said Fowler, professor of medicine (Infectious Diseases) and molecular genetics and microbiology.
The National Institutes of Health has funded a number of efforts to address antibacterial resistance, some of which Duke has participated in.
This most recent effort, funded by the National Institute of Allergy and Infectious Diseases, will establish an Antibacterial Research Leadership Group (ARLG) that will be based at Duke. It will identify, prioritize, execute and publish research in antibacterial resistance. Fowler and Henry “Chip” Chambers, MD, professor of medicine at the University of California, San Francisco and chief of the Division of Infectious Diseases at San Francisco General Hospital, are the co-primary investigators on the grant and will lead the group.